<div id="readability-page-1"><p>If you're looking for investment ideas right now, several top-rated Wall Street analysts (each with five-star ratings) believe that the following stocks are Buys with room to grow from current levels. These picks are considered to have solid upside potential based on their research. You can click on any ticker below to explore the company in depth and decide whether it deserves a spot in your portfolio.</p><h3>Claim 50% Off TipRanks Premium and Invest with Confidence </h3><ul><li>Unlock  hedge-fund level data  and  powerful investing tools  designed to help you make smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  so your portfolio is always positioned for maximum potential</li></ul> <ol> <li><strong>Gogo (GOGO) Stock</strong> – Gogo provides broadband connectivity services to the aviation industry in the United States and internationally. Analyst Scott Searle from Roth MKM reiterated his Buy rating on the stock but lowered the price target from $16 to $13 per share. Still, this equates to an upside of more than 131% from current levels.</li> <li><strong><strong>Celldex</strong> (CLDX) Stock</strong> – Celldex Therapeutics is a biopharmaceutical company that develops therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Analyst Edward Nash from Canaccord Genuity reiterated his Buy rating on the stock and maintained a price target of $62 per share. This equates to an upside of more than 119% from current levels.</li> <li><strong><strong>Centessa Pharmaceuticals</strong> (CNTA) Stock</strong> – Centessa Pharmaceuticals is a biopharmaceutical company focused on discovering and developing innovative medicines for a wide range of diseases. <span>Analyst Jay Olson from Oppenheimer </span>reiterated his Buy rating on the stock and increased the price target from $40 to $62 per share. This equates to an upside of more than 109% from current levels.</li> </ol> <p>To see the full list of recently rated stocks, visit TipRanks' Daily Stock Ratings &amp; Price Targets tool.</p></div>

CNTA

CLDX

GOGO

<p>Top-rated Wall Street analysts recommend three stocks with significant upside potential: Gogo (GOGO), Celldex (CLDX), and Centessa Pharmaceuticals (CNTA). Gogo's price target is $13, indicating a 131% upside. Celldex's target is $62, with a 119% upside. Centessa's target is $62, showing a 109% upside. Analysts maintain Buy ratings on all three stocks.</p>

These 3 Unknown Stocks Can Double, Say Five-Star Analysts – 12/11/2025